GlassScriptPhysician profile
Jamie L Seeman
NPI 1063771673
$4,329.34
in general payments reported to CMS, 2019-2025
47 companies · $525 in 2025
The $525 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $317 · 2021: $514 · 2022: $514 · 2023: $1,056 · 2024: $734 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,315.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $895.62 | 2019-2025 | Lo Loestrin Fe, Liletta, Vraylar |
| Sumitomo Pharma America, INC. | $727.05 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $354.00 | 2019-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $310.78 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Daiichi Sankyo INC. | $247.90 | 2019-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $167.11 | 2019-2025 | |
| Glaxosmithkline, LLC. | $121.16 | 2021 | |
| Organon LLC | $110.96 | 2022-2025 | Nexplanon |
| Biogen, INC. | $83.68 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $83.48 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $82.20 | 2022-2025 | |
| Pfizer INC. | $70.99 | 2021-2023 | |
| Exeltis, USA INC. | $69.64 | 2021-2023 | Slynd |
| Pacira Pharmaceuticals Incorporated | $64.27 | 2019-2024 | Exparel |
| Hologic Sales and Service, LLC | $60.38 | 2024-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Novasure |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $58.46 | 2019-2020 | |
| Ethicon US, LLC | $57.26 | 2020-2021 | |
| Therapeuticsmd, INC. | $57.15 | 2019-2021 | |
| Allergan, INC. | $48.59 | 2019 | |
| Gynesonics, INC. | $44.64 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Novo Nordisk INC | $38.81 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $38.55 | 2019-2022 | |
| Boston Scientific Corporation | $36.74 | 2019-2022 | |
| Dysis Medical, INC. | $35.99 | 2021 | |
| Sanara Medtech INC. | $33.38 | 2024 | Celleraterx |
| Acella Pharmaceuticals, LLC | $32.66 | 2024-2025 | NP Thyroid 60 |
| Mallinckrodt Enterprises LLC | $31.40 | 2019 | |
| Merck Sharp & Dohme LLC | $31.09 | 2023 | Gardasil 9 |
| Conmed Corporation | $28.87 | 2025 | Airseal |
| Dexcom, INC. | $26.78 | 2023 | Dexcom G6 Transmitter |
| Vertex Pharmaceuticals Incorporated | $25.47 | 2025 | |
| Smith+Nephew, INC. | $21.87 | 2025 | Pico |
| Genzyme Corporation | $19.42 | 2022 | |
| Roche Diagnostics Corporation | $19.07 | 2019 | |
| Galderma Laboratories, L.P. | $18.95 | 2022 | |
| Dermira, INC. | $18.43 | 2020 | |
| Applied Medical Resources Corporation | $16.35 | 2024 | |
| Sanofi Pasteur INC. | $16.34 | 2024 | |
| Abbott Laboratories | $16.20 | 2023 | Freestyle Libre 3 |
| Evofem Biosciences, INC. | $14.53 | 2022 | |
| Medtronic, INC. | $13.88 | 2024 | Truclear |
| Lilly USA, LLC | $13.83 | 2025 | Mounjaro |
| Amgen INC. | $13.80 | 2022 | |
| Exact Sciences Corporation | $13.62 | 2023 | Cologuard Collection Kit |
| Duchesnay USA Incorporated | $13.17 | 2019 | |
| Meditrina | $12.70 | 2021 | |
| Lupin INC. | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Seeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.